Any test positive | All tests negative | p | OR | CI (95%) | |
---|---|---|---|---|---|
Age, mean | 50,9 | 49,7 | 0,37* | ||
Sex, n | |||||
Male | 27 | 146 | 0,67** | 1,19 | 0,53 - 2,67 |
Female | 9 | 58 | |||
Exposure to endemic areas of VL | |||||
Yes | 15 | 77 | 0,65** | 1,18 | 0,47 - 1,60 |
No | 21 | 127 | |||
Time of HIV diagnosis, median | 16,5 | 14,5 | 0,27*** | ||
T CD4+ (cells/ml), median | 561,0 | 547,5 | 0,51*** | ||
T CD4+ (cells/ml) | |||||
< 200 | 8 | 19 | 0,03** | 2,78 | 1,11 - 6,96 |
≥ 200 | 28 | 185 | |||
Regular ART use | |||||
Yes | 29 | 182 | 0,14** | 0,5 | 0,84 - 3,64 |
No | 7 | 22 | |||
Previous opportunistic infection, n | |||||
Yes | 6 | 47 | 0,40** | 0,67 | 0,26 - 1,70 |
No | 30 | 157 | |||
Comorbidities, n | |||||
Yes | 14 | 95 | 0,40** | 0,73 | 0,35 - 1,50 |
No | 22 | 109 | |||
Presence of signal/symptoms compatible with visceral leishmaniasis | |||||
Yes | 3 | 15 | 0,74**** | 1,15 | 0,31 - 4,18 |
No | 33 | 189 | |||
Anemia and/or leukopenia and/or thrombocytopenia, n | |||||
Yes | 7 | 51 | 0,47** | 0,72 | 0,30 - 1,75 |
No | 29 | 153 |